High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma

被引:45
作者
Kubonishi, I [1 ]
Bandobashi, K [1 ]
Murata, N [1 ]
Daibata, M [1 ]
Ido, E [1 ]
Sonobe, H [1 ]
Ohtsuki, Y [1 ]
Miyoshi, I [1 ]
机构
[1] KOCHI MED SCH,DEPT PATHOL,KOCHI 783,JAPAN
关键词
Ki-1; lymphoma; CA125; IL-6; IL-6-dependent cell line; aggressive lymphoma;
D O I
10.1046/j.1365-2141.1997.2383054.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mie report a 53-year-old-man with an aggressive Ki-l lymphoma who had high serum CA125, a marker protein of the epithelial ovarian cancer, and interleukin-6 (IL-6) concentrations. Both CA125 and IL-6 levels decreased after chemotherapy and elevated with disease progression. The patient's lymphoma cells obtained before chemotherapy grew continuously in vitro, were IL-6 dependent and were found to secrete CA125 in culture medium. These results indicate that CA125 can be secreted by Ki-l lymphoma cells and IL-6 may promote the growth of Ki-1 lymphoma cells.
引用
收藏
页码:450 / 452
页数:3
相关论文
共 10 条
[1]  
APEL RL, 1995, ARCH PATHOL LAB MED, V119, P373
[2]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[3]   REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].
BAST, RC ;
FEENEY, M ;
LAZARUS, H ;
NADLER, LM ;
COLVIN, RB ;
KNAPP, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337
[4]   OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].
CANNEY, PA ;
MOORE, M ;
WILKINSON, PM ;
JAMES, RD .
BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769
[5]   AUTOCRINE GENERATION AND REQUIREMENT OF BSF-2/IL-6 FOR HUMAN MULTIPLE MYELOMAS [J].
KAWANO, M ;
HIRANO, T ;
MATSUDA, T ;
TAGA, T ;
HORII, Y ;
IWATO, K ;
ASAOKU, H ;
TANG, B ;
TANABE, O ;
TANAKA, H ;
KURAMOTO, A ;
KISHIMOTO, T .
NATURE, 1988, 332 (6159) :83-85
[6]   CA-125 - A TUMOR-MARKER IN NON-HODGKINS-LYMPHOMAS [J].
PABST, T ;
LUDWIG, C .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1827-1828
[7]  
Rodriguez J M, 1994, Clin Oncol (R Coll Radiol), V6, P137, DOI 10.1016/S0936-6555(05)80119-0
[8]   CA125 AND MALIGNANT-LYMPHOMAS [J].
SEBBAN, C ;
LASNE, Y ;
BERENGUER, V ;
ARCHIMBAUD, E ;
DEVAUX, Y ;
VIALA, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) :359-360
[9]   SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH PROGNOSIS IN DIFFUSE LARGE-CELL LYMPHOMA [J].
SEYMOUR, JF ;
TALPAZ, M ;
CABANILLAS, F ;
WETZLER, M ;
KURZROCK, R .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :575-582
[10]  
SHIMIZU S, 1988, BLOOD, V71, P196